ExL Pharma’s 4th Annual Drug Pricing & Reimbursement Conference continues to serve as the leading event for information exchange on the latest regulations and strategies for ongoing compliance and implementation of The Deficit Reduction Act, Part D, Contracting and Reimbursement. Participants will take home the latest information for how to execute a winning P&R strategy.

Last year’s Pricing & Reimbursement conference was intentionally scheduled to take place immediately following the ’07 CMS updates on DRA regulations. This timeliness, coupled with a compelling agenda of industry experts, led to this event to be the most successful edition in the history of this conference with over 100+ participants representing the gamut of industry. This year our goal is to once again provide the most relevant topic areas and grow the conference further. Cutting edge topics will be discussed in detail from
Follow On Biologics and the much needed Regulatory Pathways to Assessment of Sustainability and Single Payor issues. All sides will be examined both strategic and policy issues for Pricing, Reimbursement and Contracting from an array of Policy and Operations experts drawn from Pharma, Legal, Government Affairs, Outcomes and Consulting.